M&A Talks Europe

5. Sanofi spin-off: bidding war over the future of Pharma

30 min · 14. okt. 2024
episode 5. Sanofi spin-off: bidding war over the future of Pharma cover

Beskrivelse

In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af M&A Talks Europe-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

5 episoder